SCM Bioscience (CEO Song Soon-wook) will present a stem cell treatment drug in 'BIO KOREA 2017' held at COEX from April 12th(Wednesday) to 14th(Friday).
SCM Bioscience is a company that has original technology related to the separation of stem cells and the manufacture of therapeutic agents. In this exhibition, they present stem cell treatment agent made by layer separation culture high purity stem cell separation technology.
This is the therapeutic agent manufactured with an idea based on the fact that mesenchymal stem cells have a high therapeutic effect on the immune diseases, and in addition to lowering costs using small stem cells, its characteristic is that it shortens the treatment period and maintains the improved condition continuously.
Song Soon-wook, CEO of SCM Bioscience, said, "This drug was developed for patients with intractable disease," and said "We hope to enter the Japan and China and further into America and Europe market in the future, and we are looking for a global partner who can join us."
On the other hand, BIO KOREA 2017 is one of the main pharmaceutical and bio exhibitions in Korea, and we can see the latest trend of bio industry there which is attracting attentions as the new growth engine. In addition to the exhibition, various programs such as business forums, conferences, job fair, investor fair, meditech fair, and PICE Korea will take place at the same time.
→ Go to 'BIO KOREA 2017' News Page